RL
50
-12
BMY
53
2
KO
49
-16
NOC
45
-2
IP
53
-4
DD
34
-4
GRMN
43
3
DRI
70
-2
TRV
49
-3
EQT
59
6
ESS
47
-3
XEL
60
-9
TMO
46
2
CVS
56
-2
URBN
51
-3
AA
50
-3
ZION
64
4
XOM
57
-5
KR
61
2
LEG
22
9
RL
50
-12
BMY
53
2
KO
49
-16
NOC
45
-2
IP
53
-4
DD
34
-4
GRMN
43
3
DRI
70
-2
TRV
49
-3
EQT
59
6
ESS
47
-3
XEL
60
-9
TMO
46
2
CVS
56
-2
URBN
51
-3
AA
50
-3
ZION
64
4
XOM
57
-5
KR
61
2
LEG
22
9
Financhill
Back

ProShares UltraShort QQQ Vs. Alnylam Pharmaceuticals Industry Stock Comparison

Sell
47

QID
ProShares UltraShort QQQ

Last Price:
$35.17
Seasonality Move:
-11.47%
Buy
61

ALNY
Alnylam Pharmaceuticals

Last Price:
$291.94
Seasonality Move:
3.3%
Sell
47
ProShares UltraShort QQQ (QID) is a Sell

Is ProShares UltraShort QQQ a Buy, Sell or Hold?

  • The current ProShares UltraShort QQQ [QID] share price is $36.75. The Score for QID is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
  • QID is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
61
Alnylam Pharmaceuticals (ALNY) is a Buy

Is Alnylam Pharmaceuticals a Buy, Sell or Hold?

  • The current Alnylam Pharmaceuticals [ALNY] share price is $283.34. The Score for ALNY is 61, which is 22% above its historic median score of 50, and infers lower risk than normal.
  • ALNY is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

QID Stock Price Chart

What is ProShares UltraShort QQQ's stock price today?

  • The ProShares UltraShort QQQ share price today is $36.75
    The current trend is moderately bearish and QID is experiencing selling pressure, which indicates risk of future bearish movement.

ALNY Stock Price Chart

What is Alnylam Pharmaceuticals's stock price today?

  • The Alnylam Pharmaceuticals share price today is $283.34
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ALNY is experiencing buying pressure, which is a positive indicator for future bullish movement.

QID Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 1.46 Buy
Relative Strength Index (14 RSI): 57.91 Buy
Chaikin Money Flow: -4881882 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (31.13 - 37.15) Buy
Bollinger Bands (100): (30.74 - 35.16) Buy

ALNY Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.81 Buy
Relative Strength Index (14 RSI): 68.89 Buy
Chaikin Money Flow: 1798941 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (239.98 - 259.48) Buy
Bollinger Bands (100): (240.26 - 271.94) Buy

QID Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 37.22 Sell
20-day SMA: 35.27 Buy
50-day SMA: 32.82 Buy
200-day SMA: 35.88 Buy
8-day EMA: 36.78 Sell
20-day EMA: 35.45 Buy
50-day EMA: 33.83 Buy
200-day EMA: 37.38 Sell

ALNY Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 251.71 Buy
20-day SMA: 247.77 Buy
50-day SMA: 256.39 Buy
200-day SMA: 250.79 Buy
8-day EMA: 256.23 Buy
20-day EMA: 252.43 Buy
50-day EMA: 253.95 Buy
200-day EMA: 242.96 Buy

ProShares UltraShort QQQ Earnings Growth & QID Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Alnylam Pharmaceuticals Earnings Growth & ALNY Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.91 per share, an increase next quarter of $0.05 per share, an increase this year of $0.95 per share, and an increase next year of $2.74 per share.

ProShares UltraShort QQQ Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Alnylam Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):